148 related articles for article (PubMed ID: 17523192)
1. Bladder ultrasound in the evaluation of the efficacy of dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux.
Ozcan C; Ergün R; Ozbek SS; Avanoğlu A; Ulman I
J Clin Ultrasound; 2007 Sep; 35(7):357-62. PubMed ID: 17523192
[TBL] [Abstract][Full Text] [Related]
2. The appearance of dextranomer-hyaluronic acid copolymer implants on ultrasound may predict resolution of vesicoureteral reflux after injection therapy.
Park KJ; Jeon TY; Yoo SY; Kim JH; Eo H; Song KD
Clin Radiol; 2014 Sep; 69(9):939-44. PubMed ID: 24865315
[TBL] [Abstract][Full Text] [Related]
3. Dextranomer/hyaluronic acid endoscopic injection is effective in the treatment of intermediate and high grade vesicoureteral reflux in patients with complete duplex systems.
Hunziker M; Mohanan N; Puri P
J Urol; 2013 May; 189(5):1876-81. PubMed ID: 23159268
[TBL] [Abstract][Full Text] [Related]
4. Single center experience with endoscopic subureteral dextranomer/hyaluronic acid injection as first line treatment in 1,551 children with intermediate and high grade vesicoureteral reflux.
Puri P; Kutasy B; Colhoun E; Hunziker M
J Urol; 2012 Oct; 188(4 Suppl):1485-9. PubMed ID: 22906657
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic treatment of moderate and high grade vesicoureteral reflux in infants using dextranomer/hyaluronic acid.
Puri P; Mohanan N; Menezes M; Colhoun E
J Urol; 2007 Oct; 178(4 Pt 2):1714-6; discussion 1717. PubMed ID: 17707016
[TBL] [Abstract][Full Text] [Related]
6. The role of intraoperative cystography following the injection of dextranomer/hyaluronic acid copolymer.
Palmer LS
J Urol; 2008 Mar; 179(3):1118-20; discussion 1121. PubMed ID: 18206944
[TBL] [Abstract][Full Text] [Related]
7. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospitals of Atlanta experience.
Kirsch AJ; Perez-Brayfield MR; Scherz HC
J Urol; 2003 Jul; 170(1):211-5. PubMed ID: 12796692
[TBL] [Abstract][Full Text] [Related]
8. Febrile urinary tract infections after ureteroneocystostomy and subureteral injection of dextranomer/hyaluronic acid for vesicoureteral reflux--do choice of procedure and success matter?
Dwyer ME; Husmann DA; Rathbun SR; Weight CJ; Kramer SA
J Urol; 2013 Jan; 189(1):275-82. PubMed ID: 23174239
[TBL] [Abstract][Full Text] [Related]
9. Multivariate comparison of the efficacy of intraureteral versus subtrigonal techniques of dextranomer/hyaluronic acid injection.
Routh JC; Reinberg Y; Ashley RA; Inman BA; Wolpert JJ; Vandersteen DR; Husmann DA; Kramer SA
J Urol; 2007 Oct; 178(4 Pt 2):1702-5; discussion 1705-6. PubMed ID: 17707019
[TBL] [Abstract][Full Text] [Related]
10. Treatment of vesicoureteral reflux using endoscopic injection of nonanimal stabilized hyaluronic acid/dextranomer gel: initial experience in pediatric patients by a single surgeon.
Yu RN; Roth DR
Pediatrics; 2006 Aug; 118(2):698-703. PubMed ID: 16882825
[TBL] [Abstract][Full Text] [Related]
11. Appearance of dextranomer/hyaluronic Acid copolymer implants on computerized tomography after endoscopic treatment of vesicoureteral reflux in children.
Cerwinka WH; Qian J; Easley KA; Scherz HC; Kirsch AJ
J Urol; 2009 Mar; 181(3):1324-8; discussion 1329. PubMed ID: 19157427
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings.
Stenberg A; Larsson E; Läckgren G
J Urol; 2003 Mar; 169(3):1109-13. PubMed ID: 12576864
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux.
Moore K; Bolduc S
J Urol; 2014 Dec; 192(6):1794-9. PubMed ID: 24928269
[TBL] [Abstract][Full Text] [Related]
14. Long-term followup after endoscopic treatment of vesicoureteral reflux with dextranomer/hyaluronic acid copolymer in patients with neurogenic bladder.
Polackwich AS; Skoog SJ; Austin JC
J Urol; 2012 Oct; 188(4 Suppl):1511-5. PubMed ID: 22910250
[TBL] [Abstract][Full Text] [Related]
15. The outcomes of two different bulking agents (dextranomer hyaluronic acid copolymer and polyacrylate-polyalcohol copolymer) in the treatment of primary vesico-ureteral reflux.
Taşkinlar H; Avlan D; Bahadir GB; Delibaş A; Nayci A
Int Braz J Urol; 2016; 42(3):514-20. PubMed ID: 27286115
[TBL] [Abstract][Full Text] [Related]
16. Prospective study using a new bulking agent for the treatment of vesicoureteral reflux: polyacrylamide hydrogel.
Cloutier J; Blais AS; Moore K; Bolduc S
J Urol; 2013 Sep; 190(3):1034-7. PubMed ID: 23538241
[TBL] [Abstract][Full Text] [Related]
17. Subureteral dextranomer/hyaluronic acid injection as first line treatment in the management of high grade vesicoureteral reflux.
Puri P; Pirker M; Mohanan N; Dawrant M; Dass L; Colhoun E
J Urol; 2006 Oct; 176(4 Pt 2):1856-9; discussion 1859-60. PubMed ID: 16945672
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Bladder Ultrasound in Prediction of Resolution of Vesicoureteral Reflux After Endoscopic Subureteral Hyaluronic Acid/Dextranomer (Deflux) Injection.
Aboutaleb H; Eldib DB; Farahat Y; Abouelgreed TA; Zanaty F
Urology; 2022 Jul; 165():299-304. PubMed ID: 35065987
[TBL] [Abstract][Full Text] [Related]
19. Subureteral injection of dextranomer/hyaluronic acid copolymer for persistent vesicoureteral reflux following ureteroneocystostomy.
Jung C; DeMarco RT; Lowrance WT; Pope JC; Adams MC; Dietrich MS; Brock JW
J Urol; 2007 Jan; 177(1):312-5. PubMed ID: 17162075
[TBL] [Abstract][Full Text] [Related]
20. Can we rely on the presence of dextranomer-hyaluronic acid copolymer mounds on ultrasound to predict vesicoureteral reflux resolution after injection therapy?
Zamilpa I; Koyle MA; Grady RW; Joyner BD; Shnorhavorian M; Lendvay TS
J Urol; 2011 Jun; 185(6 Suppl):2536-41. PubMed ID: 21555031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
